Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Tolerability of Artesunate Amodiaquine Versus Chloroquine in the Treatment of Uncomplicated Plasmodium Vivax Malaria
This study is currently recruiting participants.
Verified April 2013 by Sanofi
Study NCT01378286   Information provided by Sanofi

First Received on June 20, 2011.   Last Updated on April 16, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Malaria
Additional conditions recognized in this trial
Malaria, Vivax
More general conditions related to this trial
Parasitic Diseases
Protozoan Infections
Interventions listed in this trial
ARTESUNATE + AMODIAQUINE
Chloroquine
Additional drug interventions recognized in this trial
Amodiaquine
Artesunate
Chloroquine diphosphate
More general drug interventions related to this trial
Amebicides
Analgesics
Analgesics, Non-Narcotic
Anthelmintics
Anti-Infective Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antimalarials
Antinematodal Agents
Antiparasitic Agents
Antiprotozoal Agents
Antirheumatic Agents
Central Nervous System Agents
Filaricides
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Sanofi


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services